SISTEMA RENINA-ANGIOTENSINA-ALDOSTERONA Y COVID-19
Renin-angiotensin system at the heart of COVID-19 pandemic.
Biochimie. 2020 Apr 16;174:30-33.
https://doi-org.pbidi.unam.mx:2443/10.1016/j.biochi.2020.04.008
https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S030090842030078X?via%3Dihub
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19.
N Engl J Med. 2020 Apr 23;382(17):1653-1659.
https://doi-org.pbidi.unam.mx:2443/10.1056/NEJMsr2005760
Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics.
Drug Dev Res. 2020 Mar 4.
https://doi-org.pbidi.unam.mx:2443/10.1002/ddr.21656
https://onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/full/10.1002/ddr.21656
Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic.
Nat Rev Nephrol. 2020 Apr 3.
https://doi.org/10.1038/s41581-020-0279-4
https://www-nature-com.pbidi.unam.mx:2443/articles/s41581-020-0279-4
Might renin–angiotensin system blockers play a role in the COVID-19 pandemic?
Eur Heart J Cardiovasc Pharmacother. 2020 Apr 14. pii: pvaa030
https://doi-org.pbidi.unam.mx:2443/10.1093/ehjcvp/pvaa030
Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus.
J Virol. 2020 Mar 17;94(7). pii: e00127-20
https://doi.org/10.1128/JVI.00127-20
https://jvi-asm-org.pbidi.unam.mx:2443/content/94/7/e00127-20.long
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Cell 181, 1–10, April 16, 2020.
https://doi.org/10.1016/j.cell.2020.02.052
https://www-sciencedirect-com.pbidi.unam.mx:2443/science/article/pii/S0092867420302294?via%3Dihub
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.
Science. 2020 Mar 27;367(6485):1444-1448
doi: 10.1126/science.abb2762
https://dx-doi-org.pbidi.unam.mx:2443/10.1126%2Fscience.abb2762
https://science-sciencemag-org.pbidi.unam.mx:2443/content/367/6485/1444.long
Risks of ACE inhibitor and ARB usage in COVID-19: evaluating the evidence.
Clin Pharmacol Ther. 2020 Apr 22.
https://doi-org.pbidi.unam.mx:2443/10.1002/cpt.1863
https://ascpt-onlinelibrary-wiley-com.pbidi.unam.mx:2443/doi/abs/10.1002/cpt.1863
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
Cardiovasc Res. 2020 Apr 17.
https://doi-org.pbidi.unam.mx:2443/10.1093/cvr/cvaa096
Renin-Angiotensin System Inhibition in Cardiovascular Patients at the Time of COVID19: Much Ado for Nothing? A Statement of Activity from the Directors of the Board and the Scientific Directors of the Italian Society of Hypertension.
High Blood Press Cardiovasc Prev. 2020 Apr;27(2):105-108.
https://doi.org/10.1007/s40292-020-00380-3
https://link-springer-com.pbidi.unam.mx:2443/article/10.1007%2Fs40292-020-00380-3
Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients.
Elife. 2020 Apr 6;9. pii: e57278.
doi: 10.7554/eLife.57278
